The Effect of Photobiomodulation on Pressure Ulcers

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnkara Medipol University

About this trial

Photobiomodulation Group (Intervention Group):

Before the intervention, the patient's skin sensitivity to light will be tested by applying light for 3 minutes to one-fourth of the forearm skin. If redness occurs and persists for more than 2 hours, this indicates photosensitivity, and the intervention will not be performed.

The Patient Information Form will be completed during the first meeting with the patients included in the study. Subsequently, blood values will be determined, the Patient Assessment Form will be filled out, vital signs will be measured, and then the intervention will begin. After routine wound care/cleaning procedures in the intensive care unit, without applying any medication, cream, or lotion to the wound area, red light (660 nm wavelength) will be applied to the wound area for 5 minutes at a distance of 55 cm during the first 3 days, and for 10 minutes at the same distance on the following days. This application will continue once daily for 14 days. Wound assessments will be performed, and photographs will be taken on Day 1, Day 4, Day 7, and Day 14 (Baracho et al., 2021; Viecelli et al., 2024; Lima et al., 2020).

Control Group:

The Patient Information Form will be completed during the first meeting with the patients included in the study. Subsequently, blood values will be determined, the Patient Assessment Form will be filled out, and vital signs will be measured. No intervention will be performed other than the routine wound care procedure carried out in the intensive care unit. Wound assessments will be performed, and photographs will be taken on Day 1, Day 4, Day 7, and Day 14, in the same manner as in the intervention group.

Eligibility criteria

Qualifiers

Patients with Stage II pressure ulcers

Patients without any skin disease

Patients with albumin, platelet, and blood glucose levels within normal ranges

Patients who will stay in the intensive care unit for 14 days or longer

Disqualifiers

Patients who do not consent to participate in the study

Patients with severe nutritional problems and those who are cachectic

Patients with severe edema (+4 or above)

Patients with diabetes mellitus

Trial design

Treatments tested in this trial

  • photobiomodulation

Treatment groups

46 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Ankara Medipol University

Lead sponsor

Fenerbahce University

Collaborator

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Collaborator